LATEST NEWS

LATEST FINANCIAL RESULTS

Q3 2016

Quarterly Results, Ended Sep 30, 2016        

annualReport-10-k

LATEST 10-K

STOCK INFORMATION

TapImmune Inc.

NSDQ: TPIV

Volume

Day's Range

$

()

Change

52 Week Range

COMPANY OVERVIEW

TapImmune, Inc. specializes in developing immunotherapies for a variety of cancers and infectious diseases designed to target tumors and metastatic disease. The company is currently conducting preclinical and clinical trials in breast and ovarian cancer to explore the promising commercial potential of its comprehensive approach to immunotherapy. Founded in 2006, TapImmune, Inc. is headquartered in Jacksonville, FL.

IR CONTACT DETAILS

TapImmune

50 N. Laura St. Suite 2500
Jacksonville, FL 32202
T: 866-359-7541
investor.relations@tapimmune.com